
Cynata Therapeutics Receives Notice of Allowance from EPO for Patent Application
Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited announced today that a Notice of Allowance has been received from the European Patent Office (EPO) for a patent application covering its proprietary Cymerus™ mesenchymal stem cell technology. The patent … Continue reading Cynata Therapeutics Receives Notice of Allowance from EPO for Patent Application